Business

Private equity majors eye minority stake in medical device company

Several major global private equity players are in advanced talks to acquire a minority stake in Romsons Group, a prominent Indian medical device manufacturer. The offer is estimated at around Rs 1,200 crore.

• By Newsdesk
• New Delhi
• Sep 13, 2025

Business

Several major global private equity players are in advanced talks to acquire a minority stake in Romsons Group, a prominent Indian medical device manufacturer. The offer is estimated at around ₹1,200 crore.

Firms such as Warburg Pincus and TA Associates have emerged as front-runners in the deal, according to sources. The Agra-based, family-run group (established in 1952) is well known for producing high-volume medical consumables like syringes, catheters, infusion sets and other disposables.

Due diligence is currently in progress, and insiders expect the transaction to conclude in the next two to four weeks. Romsons has built a strong distribution network covering hospitals all over India and exports its products to more than 100 countries.

With rising demand in critical care and diagnostic segments, Romsons has established itself as a market leader in low-cost, high-volume medtech products — a factor that has attracted the interest of investors looking for scale and global reach.

The medical devices sector in India has seen a surge in private equity and venture capital activity in recent years, boosting domestic manufacturing. The current size of the medtech market is estimated at about US$16 billion, and projections indicate it could nearly double to US$30 billion by 2030.

(Source: TNN)